BBLG Q4 2021 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$458,882

Net Income

-$177,737

EPS (Diluted)

$175.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$186,852

Free Cash Flow

-$186,850

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7M

Total Liabilities

$99,909

Stockholders' Equity

$7M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$458,882	-$206,432	-122.3%
Net Income	-$177,737	-$453,711	+60.8%